[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cefepime Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: CC96C891A359EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cefepime in global, including the following market information:

Global Cefepime Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Cefepime Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Cefepime companies in 2020 (%)

The global Cefepime market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cefepime manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefepime Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, By Type, 2020 (%)
  • Intramuscular Injection
  • Intravenous Drug Delivery
Global Cefepime Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, By Application, 2020 (%)
  • Lower Respiratory Tract Infection
  • Urinary Tract Infection
  • Skin And Soft Tissue Infections
  • Abdominal Cavity Infection
  • Gynecologic Infection
  • Sepsis
  • Neutrophilic Fever
Global Cefepime Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Cefepime Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cefepime revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Cefepime revenues share in global market, 2020 (%)

Key companies Cefepime sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Cefepime sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Baxter
  • Apotex
  • B. Braun Medical
  • Pfizer
  • Perrigo
  • Fresenius Kabi
  • Sandoz (Novartis)
  • Piramal Critical Care
  • Meitheal Pharmaceuticals
  • BMS
  • Qilu Pharmaceutical
  • Sinopharm
  • Shanghai Xinfeng Pharmaceutical
  • Hebei Huamin Pharmaceutical
  • Nanjing Haichen Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Guangzhou Baiyunshan Tianxin Pharmaceutical
  • Yuekang Pharmaceutical Group
  • Chengdu Beite Pharmaceutical
  • Jiangsu Hengrui Pharmaceutical
  • Hainan Star Pharmaceutical
  • Hainan Hailing Pharmaceutical
  • Shenzhen Xinlitai Pharmaceutical
  • Shenzhen Lijian Pharmaceutical
  • Suzhou Dongrui Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cefepime Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cefepime Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CEFEPIME OVERALL MARKET SIZE

2.1 Global Cefepime Market Size: 2021 VS 2027
2.2 Global Cefepime Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Cefepime Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Cefepime Players in Global Market
3.2 Top Global Cefepime Companies Ranked by Revenue
3.3 Global Cefepime Revenue by Companies
3.4 Global Cefepime Sales by Companies
3.5 Global Cefepime Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Cefepime Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Cefepime Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cefepime Players in Global Market
  3.8.1 List of Global Tier 1 Cefepime Companies
  3.8.2 List of Global Tier 2 and Tier 3 Cefepime Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cefepime Market Size Markets, 2021 & 2027
  4.1.2 Intramuscular Injection
  4.1.3 Intravenous Drug Delivery
4.2 By Type - Global Cefepime Revenue & Forecasts
  4.2.1 By Type - Global Cefepime Revenue, 2016-2021
  4.2.2 By Type - Global Cefepime Revenue, 2022-2027
  4.2.3 By Type - Global Cefepime Revenue Market Share, 2016-2027
4.3 By Type - Global Cefepime Sales & Forecasts
  4.3.1 By Type - Global Cefepime Sales, 2016-2021
  4.3.2 By Type - Global Cefepime Sales, 2022-2027
  4.3.3 By Type - Global Cefepime Sales Market Share, 2016-2027
4.4 By Type - Global Cefepime Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cefepime Market Size, 2021 & 2027
  5.1.2 Lower Respiratory Tract Infection
  5.1.3 Urinary Tract Infection
  5.1.4 Skin And Soft Tissue Infections
  5.1.5 Abdominal Cavity Infection
  5.1.6 Gynecologic Infection
  5.1.7 Sepsis
  5.1.8 Neutrophilic Fever
5.2 By Application - Global Cefepime Revenue & Forecasts
  5.2.1 By Application - Global Cefepime Revenue, 2016-2021
  5.2.2 By Application - Global Cefepime Revenue, 2022-2027
  5.2.3 By Application - Global Cefepime Revenue Market Share, 2016-2027
5.3 By Application - Global Cefepime Sales & Forecasts
  5.3.1 By Application - Global Cefepime Sales, 2016-2021
  5.3.2 By Application - Global Cefepime Sales, 2022-2027
  5.3.3 By Application - Global Cefepime Sales Market Share, 2016-2027
5.4 By Application - Global Cefepime Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cefepime Market Size, 2021 & 2027
6.2 By Region - Global Cefepime Revenue & Forecasts
  6.2.1 By Region - Global Cefepime Revenue, 2016-2021
  6.2.2 By Region - Global Cefepime Revenue, 2022-2027
  6.2.3 By Region - Global Cefepime Revenue Market Share, 2016-2027
6.3 By Region - Global Cefepime Sales & Forecasts
  6.3.1 By Region - Global Cefepime Sales, 2016-2021
  6.3.2 By Region - Global Cefepime Sales, 2022-2027
  6.3.3 By Region - Global Cefepime Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Cefepime Revenue, 2016-2027
  6.4.2 By Country - North America Cefepime Sales, 2016-2027
  6.4.3 US Cefepime Market Size, 2016-2027
  6.4.4 Canada Cefepime Market Size, 2016-2027
  6.4.5 Mexico Cefepime Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Cefepime Revenue, 2016-2027
  6.5.2 By Country - Europe Cefepime Sales, 2016-2027
  6.5.3 Germany Cefepime Market Size, 2016-2027
  6.5.4 France Cefepime Market Size, 2016-2027
  6.5.5 U.K. Cefepime Market Size, 2016-2027
  6.5.6 Italy Cefepime Market Size, 2016-2027
  6.5.7 Russia Cefepime Market Size, 2016-2027
  6.5.8 Nordic Countries Cefepime Market Size, 2016-2027
  6.5.9 Benelux Cefepime Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Cefepime Revenue, 2016-2027
  6.6.2 By Region - Asia Cefepime Sales, 2016-2027
  6.6.3 China Cefepime Market Size, 2016-2027
  6.6.4 Japan Cefepime Market Size, 2016-2027
  6.6.5 South Korea Cefepime Market Size, 2016-2027
  6.6.6 Southeast Asia Cefepime Market Size, 2016-2027
  6.6.7 India Cefepime Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Cefepime Revenue, 2016-2027
  6.7.2 By Country - South America Cefepime Sales, 2016-2027
  6.7.3 Brazil Cefepime Market Size, 2016-2027
  6.7.4 Argentina Cefepime Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Cefepime Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Cefepime Sales, 2016-2027
  6.8.3 Turkey Cefepime Market Size, 2016-2027
  6.8.4 Israel Cefepime Market Size, 2016-2027
  6.8.5 Saudi Arabia Cefepime Market Size, 2016-2027
  6.8.6 UAE Cefepime Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Baxter
  7.1.1 Baxter Corporate Summary
  7.1.2 Baxter Business Overview
  7.1.3 Baxter Cefepime Major Product Offerings
  7.1.4 Baxter Cefepime Sales and Revenue in Global (2016-2021)
  7.1.5 Baxter Key News
7.2 Apotex
  7.2.1 Apotex Corporate Summary
  7.2.2 Apotex Business Overview
  7.2.3 Apotex Cefepime Major Product Offerings
  7.2.4 Apotex Cefepime Sales and Revenue in Global (2016-2021)
  7.2.5 Apotex Key News
7.3 B. Braun Medical
  7.3.1 B. Braun Medical Corporate Summary
  7.3.2 B. Braun Medical Business Overview
  7.3.3 B. Braun Medical Cefepime Major Product Offerings
  7.3.4 B. Braun Medical Cefepime Sales and Revenue in Global (2016-2021)
  7.3.5 B. Braun Medical Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Cefepime Major Product Offerings
  7.4.4 Pfizer Cefepime Sales and Revenue in Global (2016-2021)
  7.4.5 Pfizer Key News
7.5 Perrigo
  7.5.1 Perrigo Corporate Summary
  7.5.2 Perrigo Business Overview
  7.5.3 Perrigo Cefepime Major Product Offerings
  7.5.4 Perrigo Cefepime Sales and Revenue in Global (2016-2021)
  7.5.5 Perrigo Key News
7.6 Fresenius Kabi
  7.6.1 Fresenius Kabi Corporate Summary
  7.6.2 Fresenius Kabi Business Overview
  7.6.3 Fresenius Kabi Cefepime Major Product Offerings
  7.6.4 Fresenius Kabi Cefepime Sales and Revenue in Global (2016-2021)
  7.6.5 Fresenius Kabi Key News
7.7 Sandoz (Novartis)
  7.7.1 Sandoz (Novartis) Corporate Summary
  7.7.2 Sandoz (Novartis) Business Overview
  7.7.3 Sandoz (Novartis) Cefepime Major Product Offerings
  7.4.4 Sandoz (Novartis) Cefepime Sales and Revenue in Global (2016-2021)
  7.7.5 Sandoz (Novartis) Key News
7.8 Piramal Critical Care
  7.8.1 Piramal Critical Care Corporate Summary
  7.8.2 Piramal Critical Care Business Overview
  7.8.3 Piramal Critical Care Cefepime Major Product Offerings
  7.8.4 Piramal Critical Care Cefepime Sales and Revenue in Global (2016-2021)
  7.8.5 Piramal Critical Care Key News
7.9 Meitheal Pharmaceuticals
  7.9.1 Meitheal Pharmaceuticals Corporate Summary
  7.9.2 Meitheal Pharmaceuticals Business Overview
  7.9.3 Meitheal Pharmaceuticals Cefepime Major Product Offerings
  7.9.4 Meitheal Pharmaceuticals Cefepime Sales and Revenue in Global (2016-2021)
  7.9.5 Meitheal Pharmaceuticals Key News
7.10 BMS
  7.10.1 BMS Corporate Summary
  7.10.2 BMS Business Overview
  7.10.3 BMS Cefepime Major Product Offerings
  7.10.4 BMS Cefepime Sales and Revenue in Global (2016-2021)
  7.10.5 BMS Key News
7.11 Qilu Pharmaceutical
  7.11.1 Qilu Pharmaceutical Corporate Summary
  7.11.2 Qilu Pharmaceutical Cefepime Business Overview
  7.11.3 Qilu Pharmaceutical Cefepime Major Product Offerings
  7.11.4 Qilu Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.11.5 Qilu Pharmaceutical Key News
7.12 Sinopharm
  7.12.1 Sinopharm Corporate Summary
  7.12.2 Sinopharm Cefepime Business Overview
  7.12.3 Sinopharm Cefepime Major Product Offerings
  7.12.4 Sinopharm Cefepime Sales and Revenue in Global (2016-2021)
  7.12.5 Sinopharm Key News
7.13 Shanghai Xinfeng Pharmaceutical
  7.13.1 Shanghai Xinfeng Pharmaceutical Corporate Summary
  7.13.2 Shanghai Xinfeng Pharmaceutical Cefepime Business Overview
  7.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Major Product Offerings
  7.13.4 Shanghai Xinfeng Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.13.5 Shanghai Xinfeng Pharmaceutical Key News
7.14 Hebei Huamin Pharmaceutical
  7.14.1 Hebei Huamin Pharmaceutical Corporate Summary
  7.14.2 Hebei Huamin Pharmaceutical Business Overview
  7.14.3 Hebei Huamin Pharmaceutical Cefepime Major Product Offerings
  7.14.4 Hebei Huamin Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.14.5 Hebei Huamin Pharmaceutical Key News
7.15 Nanjing Haichen Pharmaceutical
  7.15.1 Nanjing Haichen Pharmaceutical Corporate Summary
  7.15.2 Nanjing Haichen Pharmaceutical Business Overview
  7.15.3 Nanjing Haichen Pharmaceutical Cefepime Major Product Offerings
  7.15.4 Nanjing Haichen Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.15.5 Nanjing Haichen Pharmaceutical Key News
7.16 Shandong Luoxin Pharmaceutical Group
  7.16.1 Shandong Luoxin Pharmaceutical Group Corporate Summary
  7.16.2 Shandong Luoxin Pharmaceutical Group Business Overview
  7.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Major Product Offerings
  7.16.4 Shandong Luoxin Pharmaceutical Group Cefepime Sales and Revenue in Global (2016-2021)
  7.16.5 Shandong Luoxin Pharmaceutical Group Key News
7.17 Guangzhou Baiyunshan Tianxin Pharmaceutical
  7.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporate Summary
  7.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview
  7.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Major Product Offerings
  7.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Key News
7.18 Yuekang Pharmaceutical Group
  7.18.1 Yuekang Pharmaceutical Group Corporate Summary
  7.18.2 Yuekang Pharmaceutical Group Business Overview
  7.18.3 Yuekang Pharmaceutical Group Cefepime Major Product Offerings
  7.18.4 Yuekang Pharmaceutical Group Cefepime Sales and Revenue in Global (2016-2021)
  7.18.5 Yuekang Pharmaceutical Group Key News
7.19 Chengdu Beite Pharmaceutical
  7.19.1 Chengdu Beite Pharmaceutical Corporate Summary
  7.19.2 Chengdu Beite Pharmaceutical Business Overview
  7.19.3 Chengdu Beite Pharmaceutical Cefepime Major Product Offerings
  7.19.4 Chengdu Beite Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.19.5 Chengdu Beite Pharmaceutical Key News
7.20 Jiangsu Hengrui Pharmaceutical
  7.20.1 Jiangsu Hengrui Pharmaceutical Corporate Summary
  7.20.2 Jiangsu Hengrui Pharmaceutical Business Overview
  7.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Major Product Offerings
  7.20.4 Jiangsu Hengrui Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.20.5 Jiangsu Hengrui Pharmaceutical Key News
7.21 Hainan Star Pharmaceutical
  7.21.1 Hainan Star Pharmaceutical Corporate Summary
  7.21.2 Hainan Star Pharmaceutical Business Overview
  7.21.3 Hainan Star Pharmaceutical Cefepime Major Product Offerings
  7.21.4 Hainan Star Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.21.5 Hainan Star Pharmaceutical Key News
7.22 Hainan Hailing Pharmaceutical
  7.22.1 Hainan Hailing Pharmaceutical Corporate Summary
  7.22.2 Hainan Hailing Pharmaceutical Business Overview
  7.22.3 Hainan Hailing Pharmaceutical Cefepime Major Product Offerings
  7.22.4 Hainan Hailing Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.22.5 Hainan Hailing Pharmaceutical Key News
7.23 Shenzhen Xinlitai Pharmaceutical
  7.23.1 Shenzhen Xinlitai Pharmaceutical Corporate Summary
  7.23.2 Shenzhen Xinlitai Pharmaceutical Business Overview
  7.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Major Product Offerings
  7.23.4 Shenzhen Xinlitai Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.23.5 Shenzhen Xinlitai Pharmaceutical Key News
7.24 Shenzhen Lijian Pharmaceutical
  7.24.1 Shenzhen Lijian Pharmaceutical Corporate Summary
  7.24.2 Shenzhen Lijian Pharmaceutical Business Overview
  7.24.3 Shenzhen Lijian Pharmaceutical Cefepime Major Product Offerings
  7.24.4 Shenzhen Lijian Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.24.5 Shenzhen Lijian Pharmaceutical Key News
7.25 Suzhou Dongrui Pharmaceutical
  7.25.1 Suzhou Dongrui Pharmaceutical Corporate Summary
  7.25.2 Suzhou Dongrui Pharmaceutical Business Overview
  7.25.3 Suzhou Dongrui Pharmaceutical Cefepime Major Product Offerings
  7.25.4 Suzhou Dongrui Pharmaceutical Cefepime Sales and Revenue in Global (2016-2021)
  7.25.5 Suzhou Dongrui Pharmaceutical Key News

8 GLOBAL CEFEPIME PRODUCTION CAPACITY, ANALYSIS

8.1 Global Cefepime Production Capacity, 2016-2027
8.2 Cefepime Production Capacity of Key Manufacturers in Global Market
8.3 Global Cefepime Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CEFEPIME SUPPLY CHAIN ANALYSIS

10.1 Cefepime Industry Value Chain
10.2 Cefepime Upstream Market
10.3 Cefepime Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Cefepime Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Cefepime in Global Market
Table 2. Top Cefepime Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Cefepime Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Cefepime Revenue Share by Companies, 2016-2021
Table 5. Global Cefepime Sales by Companies, (K Units), 2016-2021
Table 6. Global Cefepime Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Cefepime Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Cefepime Product Type
Table 9. List of Global Tier 1 Cefepime Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cefepime Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cefepime Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Cefepime Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Cefepime Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Cefepime Sales (K Units), 2016-2021
Table 15. By Type - Global Cefepime Sales (K Units), 2022-2027
Table 16. By Application – Global Cefepime Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Cefepime Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Cefepime Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Cefepime Sales (K Units), 2016-2021
Table 20. By Application - Global Cefepime Sales (K Units), 2022-2027
Table 21. By Region – Global Cefepime Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Cefepime Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Cefepime Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Cefepime Sales (K Units), 2016-2021
Table 25. By Region - Global Cefepime Sales (K Units), 2022-2027
Table 26. By Country - North America Cefepime Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Cefepime Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Cefepime Sales, (K Units), 2016-2021
Table 29. By Country - North America Cefepime Sales, (K Units), 2022-2027
Table 30. By Country - Europe Cefepime Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Cefepime Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Cefepime Sales, (K Units), 2016-2021
Table 33. By Country - Europe Cefepime Sales, (K Units), 2022-2027
Table 34. By Region - Asia Cefepime Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Cefepime Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Cefepime Sales, (K Units), 2016-2021
Table 37. By Region - Asia Cefepime Sales, (K Units), 2022-2027
Table 38. By Country - South America Cefepime Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Cefepime Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Cefepime Sales, (K Units), 2016-2021
Table 41. By Country - South America Cefepime Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Cefepime Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Cefepime Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Cefepime Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Cefepime Sales, (K Units), 2022-2027
Table 46. Baxter Corporate Summary
Table 47. Baxter Cefepime Product Offerings
Table 48. Baxter Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Apotex Corporate Summary
Table 50. Apotex Cefepime Product Offerings
Table 51. Apotex Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. B. Braun Medical Corporate Summary
Table 53. B. Braun Medical Cefepime Product Offerings
Table 54. B. Braun Medical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Cefepime Product Offerings
Table 57. Pfizer Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Perrigo Corporate Summary
Table 59. Perrigo Cefepime Product Offerings
Table 60. Perrigo Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Fresenius Kabi Corporate Summary
Table 62. Fresenius Kabi Cefepime Product Offerings
Table 63. Fresenius Kabi Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Sandoz (Novartis) Corporate Summary
Table 65. Sandoz (Novartis) Cefepime Product Offerings
Table 66. Sandoz (Novartis) Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Piramal Critical Care Corporate Summary
Table 68. Piramal Critical Care Cefepime Product Offerings
Table 69. Piramal Critical Care Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Meitheal Pharmaceuticals Corporate Summary
Table 71. Meitheal Pharmaceuticals Cefepime Product Offerings
Table 72. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. BMS Corporate Summary
Table 74. BMS Cefepime Product Offerings
Table 75. BMS Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. Qilu Pharmaceutical Corporate Summary
Table 77. Qilu Pharmaceutical Cefepime Product Offerings
Table 78. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Sinopharm Corporate Summary
Table 80. Sinopharm Cefepime Product Offerings
Table 81. Sinopharm Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. Shanghai Xinfeng Pharmaceutical Corporate Summary
Table 83. Shanghai Xinfeng Pharmaceutical Cefepime Product Offerings
Table 84. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 85. Hebei Huamin Pharmaceutical Corporate Summary
Table 86. Hebei Huamin Pharmaceutical Cefepime Product Offerings
Table 87. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 88. Nanjing Haichen Pharmaceutical Corporate Summary
Table 89. Nanjing Haichen Pharmaceutical Cefepime Product Offerings
Table 90. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 91. Shandong Luoxin Pharmaceutical Group Corporate Summary
Table 92. Shandong Luoxin Pharmaceutical Group Cefepime Product Offerings
Table 93. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 94. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporate Summary
Table 95. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Offerings
Table 96. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 97. Yuekang Pharmaceutical Group Corporate Summary
Table 98. Yuekang Pharmaceutical Group Cefepime Product Offerings
Table 99. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 100. Chengdu Beite Pharmaceutical Corporate Summary
Table 101. Chengdu Beite Pharmaceutical Cefepime Product Offerings
Table 102. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 103. Jiangsu Hengrui Pharmaceutical Corporate Summary
Table 104. Jiangsu Hengrui Pharmaceutical Cefepime Product Offerings
Table 105. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 106. Hainan Star Pharmaceutical Corporate Summary
Table 107. Hainan Star Pharmaceutical Cefepime Product Offerings
Table 108. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 109. Hainan Hailing Pharmaceutical Corporate Summary
Table 110. Hainan Hailing Pharmaceutical Cefepime Product Offerings
Table 111. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 112. Shenzhen Xinlitai Pharmaceutical Corporate Summary
Table 113. Shenzhen Xinlitai Pharmaceutical Cefepime Product Offerings
Table 114. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 115. Shenzhen Lijian Pharmaceutical Corporate Summary
Table 116. Shenzhen Lijian Pharmaceutical Cefepime Product Offerings
Table 117. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 118. Suzhou Dongrui Pharmaceutical Corporate Summary
Table 119. Suzhou Dongrui Pharmaceutical Cefepime Product Offerings
Table 120. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 121. Cefepime Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 122. Global Cefepime Capacity Market Share of Key Manufacturers, 2019-2021
Table 123. Global Cefepime Production by Region, 2016-2021 (K Units)
Table 124. Global Cefepime Production by Region, 2022-2027 (K Units)
Table 125. Cefepime Market Opportunities & Trends in Global Market
Table 126. Cefepime Market Drivers in Global Market
Table 127. Cefepime Market Restraints in Global Market
Table 128. Cefepime Raw Materials
Table 129. Cefepime Raw Materials Suppliers in Global Market
Table 130. Typical Cefepime Downstream
Table 131. Cefepime Downstream Clients in Global Market
Table 132. Cefepime Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Cefepime Segment by Type
Figure 2. Cefepime Segment by Application
Figure 3. Global Cefepime Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cefepime Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cefepime Revenue, 2016-2027 (US$, Mn)
Figure 7. Cefepime Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cefepime Revenue in 2020
Figure 9. By Type - Global Cefepime Sales Market Share, 2016-2027
Figure 10. By Type - Global Cefepime Revenue Market Share, 2016-2027
Figure 11. By Type - Global Cefepime Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Cefepime Sales Market Share, 2016-2027
Figure 13. By Application - Global Cefepime Revenue Market Share, 2016-2027
Figure 14. By Application - Global Cefepime Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Cefepime Sales Market Share, 2016-2027
Figure 16. By Region - Global Cefepime Revenue Market Share, 2016-2027
Figure 17. By Country - North America Cefepime Revenue Market Share, 2016-2027
Figure 18. By Country - North America Cefepime Sales Market Share, 2016-2027
Figure 19. US Cefepime Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Cefepime Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Cefepime Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Cefepime Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Cefepime Sales Market Share, 2016-2027
Figure 24. Germany Cefepime Revenue, (US$, Mn), 2016-2027
Figure 25. France Cefepime Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Cefepime Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Cefepime Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Cefepime Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Cefepime Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Cefepime Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Cefepime Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Cefepime Sales Market Share, 2016-2027
Figure 33. China Cefepime Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Cefepime Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Cefepime Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Cefepime Revenue, (US$, Mn), 2016-2027
Figure 37. India Cefepime Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Cefepime Revenue Market Share, 2016-2027
Figure 39. By Country - South America Cefepime Sales Market Share, 2016-2027
Figure 40. Brazil Cefepime Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Cefepime Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Cefepime Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Cefepime Sales Market Share, 2016-2027
Figure 44. Turkey Cefepime Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Cefepime Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Cefepime Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Cefepime Revenue, (US$, Mn), 2016-2027
Figure 48. Global Cefepime Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Cefepime by Region, 2020 VS 2027
Figure 50. Cefepime Industry Value Chain
Figure 51. Marketing Channels


More Publications